Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Probuphine
    • Ropinirole Implant
    • T3 Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Titan FCOI Policy
    • Financial Info
    • Financials
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
  • Search

Press Releases

  • Home
  • News
  • Press Releases
News

Navigate News

  • Overview
  • Press Releases
  • Events
  • Presentations
  • In the News
  • Publications
  • Posters
  • Media Resources

Press Releases

  • All News
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Appoints Dr. Kate DeVarney To Its Board Of Directors

December 30, 2019

Titan Pharmaceuticals To Present At The First Annual BioTuesdays Pre-JPM Virtual Conference

December 3, 2019

Titan Pharmaceuticals Reports Third Quarter 2019 Financial Results

November 14, 2019

Titan Pharmaceuticals To Release Third Quarter 2019 Financial Results On November 14 - Conference Call To Follow

November 7, 2019

Titan Pharmaceuticals To Present Two Posters On Probuphine® At The 10th American Conference On Pharmacometrics

October 22, 2019

Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering

October 16, 2019

Titan Pharmaceuticals and Crossroads of Southern Nevada Announce Probuphine® Availability at Crossroads Rehabilitation Facilities

October 1, 2019

Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant

September 18, 2019

Titan Pharmaceuticals Reports Second Quarter 2019 Financial Results

August 14, 2019

Titan Pharmaceuticals To Release Second Quarter 2019 Financial Results On August 14 - Conference Call To Follow

August 9, 2019

  • 1
  • 2
  • 3
  • Next »
© 2021 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap